The product of the transforming gene of Rous sarcoma virus (pp60src) is responsible for the initiation and maintenance of neoplastic transformation. This transforming protein is found within various cytoplasmic compartments and is concentrated within adhesion plaques of RSV transformed cells. The research proposed in this application involves studies on the mechanism of transformation by pp60src with specific emphasis on analyses of the interaction of pp60src with cellular components, such as adhesion plaques, and the subsequent phenotypic alterations induced by these interactions. Potential antigenic and functional domains on pp60src will be analyzed by preparing antibodies to synthetic peptides from defined regions of pp60src. Functional activity of these domains will be assessed by the ability of the antibody to neutralize either the in vitro kinase activity or the expression of other transformation parameters after microinjection into living cells. Similar techniques will be used to identify regions of pp60src involved in adhesion plaque binding, the induction of the fusiform morphology, and the loss of cell surface fibronectin. Monoclonal antibodies will be prepared to pp60src substrates (vinculin and 36K protein) and microinjection used to evaluate potential functions connected with these proteins. Microinjection also will be utilized to study intracellular movements of rhodamine-labeled pp60src. Further studies on specific functions of individual adhesion plaque proteins and their possible involvement in RSV-induced transformation will employ production of monoclonal antibodies to these proteins. Results from these studies should contribute to our understanding of the neoplastic process.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA020551-12
Application #
3165337
Study Section
Virology Study Section (VR)
Project Start
1980-02-01
Project End
1989-01-31
Budget Start
1988-02-01
Budget End
1989-01-31
Support Year
12
Fiscal Year
1988
Total Cost
Indirect Cost
Name
Fred Hutchinson Cancer Research Center
Department
Type
DUNS #
075524595
City
Seattle
State
WA
Country
United States
Zip Code
98109
Rohrschneider, L R; Fuller, J F; Wolf, I et al. (2000) Structure, function, and biology of SHIP proteins. Genes Dev 14:505-20
Bourette, R P; Rohrschneider, L R (2000) Early events in M-CSF receptor signaling. Growth Factors 17:155-66
Lucas, D M; Rohrschneider, L R (1999) A novel spliced form of SH2-containing inositol phosphatase is expressed during myeloid development. Blood 93:1922-33
Rohrschneider, L R; Bourette, R P; Lioubin, M N et al. (1997) Growth and differentiation signals regulated by the M-CSF receptor. Mol Reprod Dev 46:96-103
Carlberg, K; Rohrschneider, L R (1997) Characterization of a novel tyrosine phosphorylated 100-kDa protein that binds to SHP-2 and phosphatidylinositol 3'-kinase in myeloid cells. J Biol Chem 272:15943-50
Bourette, R P; Myles, G M; Choi, J L et al. (1997) Sequential activation of phoshatidylinositol 3-kinase and phospholipase C-gamma2 by the M-CSF receptor is necessary for differentiation signaling. EMBO J 16:5880-93
Geier, S J; Algate, P A; Carlberg, K et al. (1997) The human SHIP gene is differentially expressed in cell lineages of the bone marrow and blood. Blood 89:1876-85
Lioubin, M N; Algate, P A; Tsai, S et al. (1996) p150Ship, a signal transduction molecule with inositol polyphosphate-5-phosphatase activity. Genes Dev 10:1084-95
Bourette, R P; Myles, G M; Carlberg, K et al. (1995) Uncoupling of the proliferation and differentiation signals mediated by the murine macrophage colony-stimulating factor receptor expressed in myeloid FDC-P1 cells. Cell Growth Differ 6:631-45
Myles, G M; Brandt, C S; Carlberg, K et al. (1994) Tyrosine 569 in the c-Fms juxtamembrane domain is essential for kinase activity and macrophage colony-stimulating factor-dependent internalization. Mol Cell Biol 14:4843-54

Showing the most recent 10 out of 33 publications